30 related articles for article (PubMed ID: 10068341)
21. Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Ala-Opas M; Kosma VM
Prostate; 1999 Apr; 39(1):8-15. PubMed ID: 10221260
[TBL] [Abstract][Full Text] [Related]
22. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
23. Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferation.
Lipponen P; Aaltomaa S; Kellokoski J; Ala-Opas M; Kosma V
Eur Urol; 2000 May; 37(5):573-8. PubMed ID: 10765096
[TBL] [Abstract][Full Text] [Related]
24. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer.
Lipponen P; Aaltomaa S; Tammi R; Tammi M; Agren U; Kosma VM
Eur J Cancer; 2001 May; 37(7):849-56. PubMed ID: 11313172
[TBL] [Abstract][Full Text] [Related]
25. Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Kosma VM
Br J Cancer; 1999 May; 80(3-4):477-82. PubMed ID: 10408856
[TBL] [Abstract][Full Text] [Related]
26. Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival.
Aaltomaa S; Eskelinen M; Lipponen P
Prostate; 1999 Feb; 38(3):175-82. PubMed ID: 10068341
[TBL] [Abstract][Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
